<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/neup" ></link>
<id>urn:uuid:2991cf89-c9da-87e9-07a3-f7538ae9a5d6</id>
<updated>2026-06-18T23:17:53-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>NEUP: LYNX1 CAPITAL MANAGEMENT LP (BO) Bought (JB*) 639,110 Shares of NEUPHORIA THERAPEUTICS INC for $5.14 on 10/21</title>
<link href="http://www.insiderinsights.com/company/neup/neuphoria-therapeutics-inc/id-6268076" ></link>
<id>urn:uuid:6d2d0111-9e95-0834-76f3-3220a218a849</id>
<updated>2025-10-23T19:49:54-04:00</updated>
<summary type="html" ><![CDATA[NEUPHORIA THERAPEUTICS INC (NEUP). Recent Price: $4.37. Mkt Cap:23.6mm. 10D Vol: 74,150]]></summary>
</entry>
<entry>
<title>NEUP: LYNX1 CAPITAL MANAGEMENT LP (BO) Filed a Form 3, Becoming a Registered Insider at NEUPHORIA THERAPEUTICS INC With Initial Indirect Holdings of 236,218</title>
<link href="http://www.insiderinsights.com/company/neup/neuphoria-therapeutics-inc/id-6268074" ></link>
<id>urn:uuid:edc44539-e1de-fcea-2e42-5c0130d29b36</id>
<updated>2025-10-23T19:47:16-04:00</updated>
<summary type="html" ><![CDATA[NEUPHORIA THERAPEUTICS INC (NEUP). Recent Price: $4.37. Mkt Cap:23.6mm. 10D Vol: 74,150]]></summary>
</entry>
</feed>